ConductScience.org, home

Trial · NCT00630812

Participant flow12

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits counted
Randomisation to First DoseSTARTEDMannitol 400mg192
Randomisation to First DoseSTARTEDControl126
Randomisation to First DoseCOMPLETEDMannitol 400mg184
Randomisation to First DoseCOMPLETEDControl121
Randomisation to First DoseNOT COMPLETEDMannitol 400mg8
Randomisation to First DoseNOT COMPLETEDControl5
Double Blind Treatment PeriodSTARTEDMannitol 400mg184
Double Blind Treatment PeriodSTARTEDControl121
Double Blind Treatment PeriodCOMPLETEDMannitol 400mg153
Double Blind Treatment PeriodCOMPLETEDControl107
Double Blind Treatment PeriodNOT COMPLETEDMannitol 400mg31
Double Blind Treatment PeriodNOT COMPLETEDControl14

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00630812/flow